Re: New MD&A posted
in response to
by
posted on
Dec 18, 2019 03:55PM
I don't know how much of an increase in eGFR there was but JNJ's Canagliflozin was the first new treatment for CKD to be approved by the FDA in decades.
https://www.kidney.org/news/fda-approves-new-drug-to-treat-diabetes-related-kidney-disease
An intresting article, and the drug like ours, seems to have a synergy with SGLT2's
tada